Abstract

Submit your abstract for ESPACOMP 2021 here

Dear Colleague,

ESPACOMP, the annual meeting for the International Society for Medication Adherence, is the leading conference for researchers, clinicians, policy makers, and others interested in the science of medication adherence. Due to continuing concerns about the ongoing COVID-19 pandemic, the 25th ESPACOMP Conference will be held in an online format from November 8th to 19th 2021. This year’s ESPACOMP conference will have a special focus on Adaptability and Sustainability of Innovative Models of Care to Improve Medication Adherence

We invite you to submit an abstract here below with the findings of your latest adherence research to the ESPACOMP conference. We welcome submissions on all aspects of medication adherence research (e.g. intervention research, observational studies, implementation science, measurement studies, policy evaluation). The deadline for abstract submission is 11:59pm (CET) May 31, 2021.

All submitted abstracts will be scored by reviewers, and decisions on their acceptance will be communicated to the submitting authors by the end of July.

Due to the online format, accepted poster abstracts will be presented as small slide sets (4 slides maximum) with a recorded talk (maximum 5 minutes), rather than traditional scientific posters. Higher scoring abstracts will be selected for live oral presentation sessions. Accepted abstracts will be published in International Journal of Clinical Pharmacy.

Abstract Format:

Abstracts must be structured, with section headings for Aim, Methods, Results, Discussion, and Conclusion.
Abstracts must be limited to 250 words, including the title.
Abstracts are limited to a maximum of 8 authors.
Abstracts must adopt the ESPACOMP-endorsed ABC Taxonomy, available here
Authors must present in the abstract, in as much detail as space permits, information on the 4 minimum reporting criteria report according to the ESPACOMP EMERGE reporting guidelines. These are available here

Additional information about the meeting program will be posted at this website when it is available. Information can also be found on LinkedIn (in “Groups” search for “ESPACOMP’) or on Twitter (@SocMedAdherence).

The scientific and executive committees are continuing to plan the format for our online conference. Updates will be posted on the ESPACOMP website.

Specific questions about the ESPACOMP conference may be directed to info@espacomp.eu.

Your Name (required)

Your Email (required)

Abstract Title ( Maximum of 15 words describing the research) (required)

words. Please limit to 15 words or less With Space.

Authors. The first author should be the person who contributed most to the work, including writing of the abstract. The last author is usually a senior author (e.g. supervisor) and guarantor who accepts full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to submit.

Affiliations and Countries

Is the first/presenting author a doctoral student?

Is the first/presenting author a post-doc or within 5 years of completing their PhD or doctoral degree?

Content.
The introduction, aim, methods, results, discussion and conclusion sections must be within the 235 word limit .
Most words should be dedicated to the methods and results sections.
Authors must adopt the ESPACOMP endorsed ABC taxonomy

Authors must present in the abstract, in as much detail as space permits, information on the 4 minimum reporting criteria report according to the ESPACOMP EMERGE reporting guidelines

Introduction - Aim - Methods - Results - Discussion - Conclusion

words. Please limit to 235 words or less With Space.

Due to copyright restrictions, the abstracts of research presented at other conferences, or already published, will not be accepted for publication in the International Journal of Clinical Pharmacy. Has this work been previously presented or published?
yesno

Dear Colleague,

All submitted abstracts will be scored by reviewers, and decisions on their acceptance will be communicated to the submitting authors by the end of July.

Abstract Format:

Abstracts must be structured, with section headings for Aim, Methods, Results, Discussion, and Conclusion.

Abstracts must be limited to 250 words, including the title.

Abstracts are limited to a maximum of 8 authors.

Abstracts must adopt the ESPACOMP-endorsed ABC Taxonomy, available here

Authors must present in the abstract, in as much detail as space permits, information on the 4 minimum reporting criteria report according to the ESPACOMP EMERGE reporting guidelines. These are available here

Additional information about the meeting program will be posted at this website when it is available. Information can also be found on LinkedIn (in “Groups” search for “ESPACOMP’) or on Twitter (@SocMedAdherence).

The scientific and executive committees are continuing to plan the format for our online conference. Updates will be posted on the ESPACOMP website.

Specific questions about the ESPACOMP conference may be directed to info@espacomp.eu.

Save the Date

Publication Abstracts ESPACOMP Conference in International Journal of Clinical Pharmacy

Who is Marie Schneider